Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statistical tests for clonality.

Colin B Begg1, Kevin H Eng, Amanda J Hummer

  • 1Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 307 E. 63rd Street, Room 303, New York, New York 10021, USA. beggc@mskcc.org

Biometrics
|August 11, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The temporal dynamics of the immune response to neoadjuvant androgen deprivation therapy suggests a window-of-opportunity for checkpoint inhibitor therapy in prostate cancer.

medRxiv : the preprint server for health sciences·2026
Same author

Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Comprehensive tumor-immune profiling reveals mediators of paradoxical immune sensitivity in sarcomatoid renal cell carcinoma.

Cancer cell·2025
Same author

Two-stage subsampling variable selection for sparse high-dimensional generalized linear models.

Statistical methods in medical research·2025
Same author

A New Strategy for Evaluating the Impact of Epidemiologic Risk Factors for Cancer With Application to Melanoma.

Journal of the American Statistical Association·2025
Same author

Association of Inherited Genetic Variants with Multiple Primary Melanoma.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2025
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

A Bayesian phase I/II platform design with data augmentation accounting for delayed outcomes.

Biometrics·2026
See all related articles

This study introduces a new statistical test to determine if two tumors originated from the same cell. The method analyzes genetic markers, offering a powerful way to distinguish clonal origins from independent tumors.

Area of Science:

  • Oncology
  • Genetics
  • Biostatistics

Background:

  • Distinguishing between independent primary tumors and those with a shared clonal origin is crucial in cancer research.
  • Genetic fingerprinting using markers like loss of heterozygosity (LOH) is a common approach.

Purpose of the Study:

  • To evaluate candidate significance tests for determining the clonal origin of tumor pairs.
  • To develop a robust statistical method for assessing clonality in cancer studies.

Main Methods:

  • The study evaluates significance tests based on the correlation of LOH at individual loci.
  • A novel adaptation of Fisher's exact test is proposed, utilizing concordant mutations on the same parental allele.
  • The test statistic is the total number of loci with concordant mutations on the same parental allele.

Related Experiment Videos

Main Results:

  • The proposed test demonstrates high power in detecting clonality under various models.
  • The method is effective with a reasonable number of informative loci, ideally on distinct chromosomal arms.
  • Illustration using contralateral breast cancer studies shows the method's applicability.

Conclusions:

  • The developed test provides a simple and powerful strategy for differentiating tumors of clonal origin from independent ones.
  • Caution is advised when interpreting results due to assumptions about mutation probabilities.
  • The method enhances the ability to accurately classify tumor origins.